Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

118.21 -0.36 (-0.30%)
Official Closing Price Updated: 4:15 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,207,181
Open 118.10
Bid (Size) 118.02 (3)
Ask (Size) 118.44 (1)
Prev. Close 118.57
Today's Range 117.28 - 118.37
52wk Range 111.83 - 138.74
Shares Outstanding N/A
Dividend Yield 0.52%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech And Healthcare Portfolio Playbook For December 2023/24
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. 
Via Talk Markets
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. 
Via Talk Markets
Topics ETFs

Performance

YTD
-9.10%
-9.10%
1 Month
+4.58%
+4.58%
3 Month
-8.70%
-8.70%
6 Month
-10.32%
-10.32%
1 Year
-11.05%
-11.05%

More News

Read More
You Don't Have to Pick a Winner in Biotech. Here's Why.
Via The Motley Fool
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
Via InvestorPlace
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
Via Talk Markets
Exposures COVID-19
Three Lessons For Investing In Biotech Companies
Via Talk Markets
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
Via Talk Markets
Topics Economy
Exposures Economy
When News Moves So Fast, Stocks Can Stand Still
Via Talk Markets
Johnson & Johnson Stock: Is Now the Time to Sell?
Via InvestorPlace
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
Via Talk Markets
Fresh Look At Long Bonds
Via Talk Markets
Topics Bonds Stocks
Exposures Debt Markets US Equities
Healthcare Playbook Revisited - Growth Plus Value
Via Talk Markets
Time For Gilead Sciences-Heavy ETFs?
Via Talk Markets
Technical Correction Or Return Of The Bear Market?
Via Talk Markets
It’s Really All About the Retail Sector Now
Via Talk Markets
The 3 Best Biotech Stocks to Buy Now: September 2023
Via InvestorPlace
Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed
Via Benzinga
Topics ETFs
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
Via Talk Markets
Topics ETFs
Exposures COVID-19
BRICS And The Recent Headline
Via Talk Markets
The US Dollar And Long Bonds Doing The Dosey Doe
Via Talk Markets
5 Meme Stocks to Sell Immediately, According to AI
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Biotechnology On Drugs
Via Talk Markets
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
Via Talk Markets
3 Strong Biotech Performers To Watch As Sector Nears Breakout
Via MarketBeat
Topics ETFs
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.